APA (7th ed.) Citation

Peleg, R., Romzova, M., Kogan-Zviagin, I., Apte, R. N., & Priel, E. (2014). Modification of topoisomerases in mammospheres derived from breast cancer cell line: Clinical implications for combined treatments with tyrosine kinase inhibitors. BMC Cancer, 14(1), 1. https://doi.org/10.1186/1471-2407-14-910

Chicago Style (17th ed.) Citation

Peleg, Refael, Marianna Romzova, Inga Kogan-Zviagin, Ron N. Apte, and Esther Priel. "Modification of Topoisomerases in Mammospheres Derived from Breast Cancer Cell Line: Clinical Implications for Combined Treatments with Tyrosine Kinase Inhibitors." BMC Cancer 14, no. 1 (2014): 1. https://doi.org/10.1186/1471-2407-14-910.

MLA (9th ed.) Citation

Peleg, Refael, et al. "Modification of Topoisomerases in Mammospheres Derived from Breast Cancer Cell Line: Clinical Implications for Combined Treatments with Tyrosine Kinase Inhibitors." BMC Cancer, vol. 14, no. 1, 2014, p. 1, https://doi.org/10.1186/1471-2407-14-910.